Table 1.

Multivariate Cox proportional hazards model for OS among RAEB patients (N = 336)

CharacteristicsHazard ratio (95% CI)P
HMA-type decitabine (ref = azacitidine) 0.96 (0.70-1.31) .78 
ESA use pre-HMA (ref = No) 1.05 (0.80-1.37) .73 
Year of MDS diagnosis (ref = 2004-2005)  .96 
 2006-2007 0.95 (0.66-1.36)  
 2008 0.96 (0.65-1.40)  
Time to first HMA, mo 0.98 (0.96-1.00) .02 
Age group, y (ref = 66-69)  .14 
 70-74 1.33 (0.92-1.92)  
 75-79 1.36 (0.94-1.97)  
 80+ 1.58 (1.08-2.30)  
Sex (ref = male) 0.95 (0.75-1.21) .69 
Race other than white (ref = white) 0.76 (0.53-1.11) .16 
Hispanic (ref = no) 1.61 (0.90-2.86) .11 
Marital status (ref = married)  .06 
 Single/Div/Sep/Wid/Unmarried 1.03 (0.78-1.37)  
 Unknown 0.60 (0.39-0.94)  
Elixhauser Comorbidity Index pre-HMA (ref = 0)  .44 
 1-2 0.81 (0.59-1.12)  
 >3 0.89 (0.63-1.25)  
Disability (ref = not disabled)  .87 
 Disabled 1.05 (0.62-1.78)  
RBC transfusion group (ref = 0)  <.001 
 1-2 1.76 (1.29-2.41)  
 ≥3 1.95 (1.43-2.65)  
Platelet transfusion group (ref = 0)  .01 
 1-2 1.56 (0.95-2.57)  
 ≥3 1.89 (1.21-2.96)  
Adults 25+ y in zip code with ≤ HS education, % (ref ≤ 33%)  .46 
 33-66 1.07 (0.79-1.44)  
 ≥66 0.83 (0.50-1.37)  
Income (ref = <$33 000)  .89 
 $33 000-40 000 0.92 (0.57-1.48)  
 $40 000-50 000 0.86 (0.56-1.30)  
 ≥$50 000 0.94 (0.60-1.46)  
Metro (ref = metro area)  .30 
 Nonmetro 1.22 (0.84-1.78)  
CharacteristicsHazard ratio (95% CI)P
HMA-type decitabine (ref = azacitidine) 0.96 (0.70-1.31) .78 
ESA use pre-HMA (ref = No) 1.05 (0.80-1.37) .73 
Year of MDS diagnosis (ref = 2004-2005)  .96 
 2006-2007 0.95 (0.66-1.36)  
 2008 0.96 (0.65-1.40)  
Time to first HMA, mo 0.98 (0.96-1.00) .02 
Age group, y (ref = 66-69)  .14 
 70-74 1.33 (0.92-1.92)  
 75-79 1.36 (0.94-1.97)  
 80+ 1.58 (1.08-2.30)  
Sex (ref = male) 0.95 (0.75-1.21) .69 
Race other than white (ref = white) 0.76 (0.53-1.11) .16 
Hispanic (ref = no) 1.61 (0.90-2.86) .11 
Marital status (ref = married)  .06 
 Single/Div/Sep/Wid/Unmarried 1.03 (0.78-1.37)  
 Unknown 0.60 (0.39-0.94)  
Elixhauser Comorbidity Index pre-HMA (ref = 0)  .44 
 1-2 0.81 (0.59-1.12)  
 >3 0.89 (0.63-1.25)  
Disability (ref = not disabled)  .87 
 Disabled 1.05 (0.62-1.78)  
RBC transfusion group (ref = 0)  <.001 
 1-2 1.76 (1.29-2.41)  
 ≥3 1.95 (1.43-2.65)  
Platelet transfusion group (ref = 0)  .01 
 1-2 1.56 (0.95-2.57)  
 ≥3 1.89 (1.21-2.96)  
Adults 25+ y in zip code with ≤ HS education, % (ref ≤ 33%)  .46 
 33-66 1.07 (0.79-1.44)  
 ≥66 0.83 (0.50-1.37)  
Income (ref = <$33 000)  .89 
 $33 000-40 000 0.92 (0.57-1.48)  
 $40 000-50 000 0.86 (0.56-1.30)  
 ≥$50 000 0.94 (0.60-1.46)  
Metro (ref = metro area)  .30 
 Nonmetro 1.22 (0.84-1.78)  

Div, divorced; ESA, erythropoiesis-stimulating agent; HS, high school; ref, reference value; Sep, separated; Wid, widowed.

Close Modal

or Create an Account

Close Modal
Close Modal